Hot Life Science Investor Mandate 1: Private Wealth Group Seeking Devices, Services Providers and Later Stage Therapeutics

4 Sep

A private wealth group based in the Eastern United States invests on behalf of family offices and institutions, and makes direct investments in a variety of sectors including healthcare & life science. Investments in early-stage companies are typically in the form of equity, whereas debt investments in later-stage companies may be considered. The group’s allocations are highly variable but are generally over $1m, and are typically at least $3m. The firm primarily invests in US-based companies but Canada-based and other international companies may also be considered.

Within the life science sector the group has diverse interests, with a primary focus on medical devices at all stages of development and medical service providers (including biotech R&D services and healthcare IT companies). Investments in therapeutic drug development may also be considered but only at later stages (Phase II or later).

The group seeks to invest in solid management teams who are developing a product based on proprietary, patented technology which addresses a large market need. While the group may consider investments in pre-revenue companies, they require that a company have a defined path to revenues and will be profitable within three years.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: